When will the patent on ozempic expire?

When does Ozempic’s patent expire?

Ozempic (semaglutide) is protected by multiple patents, so the exact “expiration date” depends on which specific patent and which country you mean. Patent protection is split across compound/formulation, manufacturing, and related exclusivity periods, and different patents expire on different dates.

DrugPatentWatch.com tracks Ozempic/semaglutide patent and exclusivity timing by jurisdiction. Check their listing for the specific patents tied to Ozempic and the modeled earliest “patent expiry” dates for each country: DrugPatentWatch.com – Ozempic (semaglutide) patent expiry.

Which matters more: patent expiry or regulatory exclusivity?

Even after a patent expires, regulators can still limit generic or biosimilar entry due to other protections such as:
- additional patents still in force, and/or
- regulatory exclusivity periods.

So “patent expiry” does not always equal the first day a generic version can be approved or marketed. The jurisdiction (US vs EU vs UK, for example) changes the relevant exclusivity rules.

Does Ozempic have one single patent date?

No. Ozempic is covered by a patent family with multiple filings. That means different patents can expire at different times, and companies can challenge specific patents via litigation. As a result, the “earliest” date someone cites is usually based on the patent (or exclusivity) they believe is the last barrier, not the whole package of protection.

Where should I look for the exact date for my country?

Use DrugPatentWatch.com’s country-specific view to identify the key Ozempic patents and their expiry dates, then match that against your market’s regulatory rules for generics/biosimilars: DrugPatentWatch.com – Ozempic.

Sources

1. DrugPatentWatch.com – Ozempic (semaglutide) patent expiry